Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Myofibroma × Misoprostol × Clear all

Phase

Phase 3 4 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 2 Uterine Cervical Neoplasms 1 Myofibroma 1 Blood Loss, Surgical 1

Interventions

Uterine Myomectomy 3 Tourniquets 2 carbetocin 1 Vasopressins 1 Uterine Artery Embolization 1 Triptorelin Pamoate 1 Tranexamic Acid 1 Sevoflurane 1 Saline Solution 1 Respiration, Artificial 1 Remifentanil 1 Propofol 1 Population Groups 1 Nuclear Receptor Subfamily 4, Group A, Member 2 1 Morcellation 1 Misoprostol 1 Methylergonovine 1 Laparoscopy 1 Hysteroscopy 1 Hysterectomy, Vaginal 1 Hysterectomy 1 Ergonovine 1 Dexamethasone 1 Desflurane 1 Buspirone 1 Bupivacaine 1 Ascorbic Acid 1 Anesthesia, Spinal 1 Anesthesia, General 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06882824 2025-09-24

HEMOMYOC

University Hospital, Clermont-Ferrand

Phase NA Recruiting

Blood Loss, Surgical, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡